Robert Marcus
Stock Analyst at JP Morgan
(1.57)
# 2,505
Out of 4,497 analysts
8
Total ratings
58.82%
Success rate
10.36%
Average return
Main Sectors:
Top Industries:
7 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IART Integra LifeSciences Holdings | Upgrades: Neutral | n/a | $31.34 | - | 2 | Dec 17, 2021 | |
| BDX Becton, Dickinson and Company | Downgrades: Neutral | n/a | $230.74 | - | 1 | Aug 6, 2021 | |
| GKOS Glaukos | Downgrades: Underweight | n/a | $120.73 | - | 1 | Oct 8, 2020 | |
| TMDX TransMedics Group | Downgrades: Neutral | n/a | $147.20 | - | 1 | Oct 8, 2020 | |
| AFIB Acutus Medical | Initiates: Overweight | n/a | $0.03 | - | 1 | Aug 31, 2020 | |
| ATRC AtriCure | Maintains: Overweight | n/a | $24.17 | - | 1 | Apr 28, 2020 | |
| NVRO Nevro | Maintains: Neutral | n/a | $9.10 | - | 1 | Apr 2, 2020 |
Integra LifeSciences Holdings
Dec 17, 2021
Upgrades: Neutral
Price Target: n/a
Current: $31.34
Upside: -
Becton, Dickinson and Company
Aug 6, 2021
Downgrades: Neutral
Price Target: n/a
Current: $230.74
Upside: -
Glaukos
Oct 8, 2020
Downgrades: Underweight
Price Target: n/a
Current: $120.73
Upside: -
TransMedics Group
Oct 8, 2020
Downgrades: Neutral
Price Target: n/a
Current: $147.20
Upside: -
Acutus Medical
Aug 31, 2020
Initiates: Overweight
Price Target: n/a
Current: $0.03
Upside: -
AtriCure
Apr 28, 2020
Maintains: Overweight
Price Target: n/a
Current: $24.17
Upside: -
Nevro
Apr 2, 2020
Maintains: Neutral
Price Target: n/a
Current: $9.10
Upside: -